K2 Principal Fund’s MacroGenics MGNX Stock Holding History

K2 Principal Fund’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-14,800	Closed	-$62.9K	–	292
2024 Q2	$62.9K	Buy	+14,800	New	+$144K	0.01%	177

Other funds holding MGNX

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

K2 Principal Fund's MGNX Position: Q3 2024 in Review

K2 Principal Fund sold out of MacroGenics (MGNX) in Q3 2024, closing a stake of 14,800 shares — an estimated $62.9K sold.

K2 Principal Fund first reported a position in MGNX in Q2 2024 and held it in 1 quarter. The position peaked at $62.9K in Q2 2024. 124 funds tracked by Wall St. Rank hold MGNX as of Q3 2024.

K2 Principal Fund reported no remaining MacroGenics position as of Q3 2024 after selling out during the quarter.
K2 Principal Fund sold 14,800 MacroGenics shares in Q3 2024, an estimated $62.9K.
K2 Principal Fund first reported a position in MacroGenics in Q2 2024 and held it in 1 quarter.
K2 Principal Fund's MacroGenics position peaked at $62.9K in Q2 2024.
124 funds tracked by Wall St. Rank held MacroGenics as of Q3 2024.

Based on K2 Principal Fund's 13F filing for Q3 2024, filed 15 Nov 2024.